CD8A and graft versus host disease: Taken together, our data suggested that Dara may alleviate xeno-GVHD not only by inhibition of the proliferation, activation and differentiation of CD8+ cytotoxic T cells, but also by increasing the frequency of immunosuppressive T cells.